-
Article
Correction to: Drug repurposing using computational methods to identify therapeutic options for COVID-19
-
Article
Correction to: In silico evidence for prednisone and progesterone efficacy in recurrent implantation failure treatment
-
Article
Potential for Polyethylene Terephthalate (PET) Degradation Revealed by Metabarcoding and Bacterial Isolates from Soil Around a Bitumen Source in Southwestern Iran
The rapid global growth of plastic production and waste are harbingers of increasing pollution in terrestrial and marine ecosystems for which safe and effective methods of disposal and degradation must be purs...
-
Article
A simple method for the production of nano polyethylene particles for rapid assay of polyethylene biodegradation
Synthetic polymers, such as polyethylene (PE), are produced daily in large quantities and, due to their unique properties, like durability and low cost, consumed in various capacities worldwide, subsequently a...
-
Article
In-situ production of silver nanobiocomposite using surface layer protein of Lactobacillus helveticus and aqueous extract of dried Juglans regia green husk and investigation of antibacterial activity
One way to overcome the challenge of the active surface of nanoparticles and their tendency to aggregate is to use a biopolymer. The surface layer protein (S-layer) is a good candidate for trap** nanoparticl...
-
Article
In silico evidence for prednisone and progesterone efficacy in recurrent implantation failure treatment
Increased expression and activation of tumor necrosis factor-α (TNF-α) could lead to recurrent implantation failure (RIF). Therefore, TNF-α inhibition may be a strategic way to enhance the implantation rate in...
-
Article
Drug repurposing using computational methods to identify therapeutic options for COVID-19
Recently, the world has been dealing with a new type of coronavirus called COVID-19 that in terms of symptoms is similar to the SARS coronavirus. Unfortunately, researchers could not find a registered therapy ...
-
Article
In silico identification of new inhibitors for βeta-2-glycoprotein I as a major antigen in antiphospholipid antibody syndrome
Beta 2 glycoprotein I (β2GPI) is a major antigen for autoantibodies present in antiphospholipid antibody syndrome (APS). β2GPI is a single polypeptide with five repeated domains and different conformations. Th...
